The Body: The Complete HIV/AIDS Resource
Follow Us Follow Us on Facebook Follow Us on Twitter Download Our App 
Professionals >> Visit The Body PROThe Body en Espanol
Ask the Experts About

Nutrition and ExerciseNutrition and Exercise
Rollover images to visit our other forums!
Recent AnswersAsk a Question
  • Email Email
  • Glossary Glossary


Jul 14, 2011

Hello... Can u give me an update re: this drug. I thought there would be some movement by now. Today's date 7-8-2011..

I'm in East Tx. an in need of this(drug)

CD4 has fallen big time...VL 40 thousand and this would give me a 3rd drug.

Longtime positive....thanks

Response from Mr. Vergel

I am assuming that you have no HIV treatment options left.

TNX 355 is called ibalizumab, a CD4 monoclonal antibody that is administered intravenously.

I just wrote an update to help doctors who do not have any experience in applying for pre appoval access of investigational drugs for people who have run out of options and have declining health. You may want to print this out for your doctor to see if he/she is able to help you out.

Let me know how it goes since I have a lot of experience in the area.

How You Can Help Your Patients Who Are Running Out of HIV Treatment Options

Nelson Vergel

HGH while on Meds, Good or Bad??
Fosamax and hiv

  • Email Email
  • Glossary Glossary

 Get Email Notifications When This Forum Updates or Subscribe With RSS



This forum is designed for educational purposes only, and experts are not rendering medical, mental health, legal or other professional advice or services. If you have or suspect you may have a medical, mental health, legal or other problem that requires advice, consult your own caregiver, attorney or other qualified professional.

Experts appearing on this page are independent and are solely responsible for editing and fact-checking their material. Neither nor any advertiser is the publisher or speaker of posted visitors' questions or the experts' material.

Review our complete terms of use and copyright notice.

Powered by ExpertViewpoint